Droxidopa Market - Forecast (2023 - 2028) PowerPoint PPT Presentation

presentation player overlay
About This Presentation
Transcript and Presenter's Notes

Title: Droxidopa Market - Forecast (2023 - 2028)


1
Droxidopa MarketMarket size, Industry outlook,
Market Forecast, Demand Analysis, Market Share,
Market Report 2021-2026
Contact Venkat Reddy sales_at_industryarc.com
(1) 970-236-3677
2
Download PDF Brochure
  • The Droxidopa Market size is forecast to
    reach US487.1 million by 2027, after growing at
    a CAGR of 7.8 during 2022-2027. Droxidopa is a
    medication widely used to treat symptoms of
    neurogenic orthostatic hypotension that increases
    the deficient supply of norepinephrine as well as
    dopamine in patients with neurogenic orthostatic
    hypotension in the youth population. It is mainly
    caused by dopamine beta-hydroxylase deficiency,
    non-diabetic autonomic neuropathy, and primary
    autonomic failure. Droxidopa crosses the blood
    brain barrier, to convert norepinephrine via
    decarboxylation by L-aromatic-amino-acid
    decarboxylase. 

Inquiry Before Buying
Email sales_at_industryarc.com
3
Download PDF Brochure
  • Key Takeaways
  • Increasing research development to treat
    symptomatic neurogenic orthostatic hypotension
    (nOH) caused by dopamine beta-hydroxylase
    deficiency and others will drive the Droxidopa
    Market.
  • The growing working class and increasing stress
    levels resulting in increasing neurogenic
    orthostatic hypotension diseases will boost the
    Droxidopa Market by 2027

Inquiry Before Buying
Email sales_at_industryarc.com
4
Download PDF Brochure
By Distribution Channel- Segment
Analysis The capsule segments accounted for
around 40 of the market share in 2021 and are
estimated to grow at a significant CAGR during
the forecast period. Capsules observed the
nutrients present in a better way than the
nutrients obtained from other forms. The drugs
which are present in the capsules are considered
to enter the bloodstream of people immediately.
Capsules of droxidopa are widely used to treat
neurogenic orthostatic hypotension mainly caused
due to deficient supply of norepinephrine to give
immediate relief to the patient.
Inquiry Before Buying
Email sales_at_industryarc.com
5
Download PDF Brochure
  • Droxidopa Market Outlook
  • Piramal Enterprises Limited
  • Lupin Ltd
  • Clarochem Ireland Ltd
  • Estechpharma Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • JINLAN Pharm-Drugs Technology Co., Ltd.
  • Chongqing Shenghuaxi Pharm Co., Ltd.
  • Hikma Pharmaceuticals PLC
  • Chelsea Therapeutics International, Ltd.
  • Dainippon Sumitomo Pharma

Inquiry Before Buying
Email sales_at_industryarc.com
6
Download PDF Brochure
Droxidopa Market Forecast
(2023 - 2028) Learn More About the Report _at_
https//www.industryarc.com/Research/Global-Droxi
dopa-Industry-Market-Research-511680
Inquiry Before Buying
Email sales_at_industryarc.com
7
Download PDF Brochure
  • You Can Customize the Report as Per Your Need.
    We have included Some Customization Options
  • Company Profile
  • Analyst Briefing
  • Data Tables
  • Key Contacts
  • Free Customization
  • Purchase Full Report _at_ https//www.industryarc.com
    /purchasereport.php?id511680

Inquiry Before Buying
Email sales_at_industryarc.com
8
Download PDF Brochure
For More Details Contact Venkat
Reddy Contact (1) 970-236-3677 Email
sales_at_industryarc.com Connect with us on LinkedIn
_at_ http//www.linkedin.com/company/industryarc
Contact (1) 970-236-3677
Inquiry Before Buying
Email sales_at_industryarc.com
Write a Comment
User Comments (0)
About PowerShow.com